Fortis Suguna Hospital acquisition adds 110 beds in Bengaluru, with planned clinical upgrades and expansion offering potential for long-term growth.
Artiva's AlloNK discontinuation raises questions about autoimmune cell therapy safety, fludarabine toxicity, and whether early clinical responses can deliver lasting benefits in autoimmune disease treatment.
The Lancet ranking reveals India’s heat blind spot as infants and older adults face rising heatwave exposure and inadequate targeted protection.
Ayushman Bharat's expanding health-data infrastructure could help Indian pharmaceutical researchers evaluate treatment outcomes, strengthen drug safety monitoring and improve real-world evidence.
AIG Hospitals and Boston Scientific are expanding specialist training to support access to advanced gastrointestinal procedures beyond major Indian cities.
A KGMU report highlights gaps in breast cancer screening follow-up in Uttar Pradesh, raising concerns about timely diagnosis and access to care.
India has come a long way in the management of cardiovascular disease. With advances in diagnostics, interventional cardiology and cardiac surgery, patients with complex heart conditions have more options than ever before. However, access to newer su
The World Health Organization says the first human Shamonda case in France is unlikely to cause wider spread or public health risks.
Tamil Nadu's dengue vaccine pilot will assess Qdenga's local performance, safety and delivery to inform future vaccination decisions.
Leucine Rich Bio's vaginal microbiome test brings personalised women's health insights into focus, raising questions about clinical utility and diagnostic evidence.
.jpg)
, CDSCO.jpg)
